What is BRAFTOVI?

•

in combination with a medicine called binimetinib to treat people with a type of skin cancer called melanoma:

o

that has spread to other parts of the body or cannot be removed by surgery, and

o

that has a certain type of abnormal "BRAF" gene

•

in combination with a medicine called cetuximab and mFOLFOX6 (fluorouracil, leucovorin and oxaliplatin) to treat people with cancer of the colon or rectum (colorectal cancer):

o

that has spread to other parts of the body, and

o

that has a certain type of abnormal "BRAF" gene

•

in combination with a medicine called cetuximab to treat adults with cancer of the colon or rectum (colorectal cancer) after past treatment:

o

that has spread to other parts of the body, and

o

that has a certain type of abnormal "BRAF" gene

•

in combination with a medicine called binimetinib to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC):

o

that has spread to other parts of the body, and

o

that has a certain type of abnormal "BRAF" gene

BRAFTOVI should not be used to treat people with wild-type BRAF melanoma, wild-type BRAF colorectal cancer, or wild-type BRAF NSCLC. Your healthcare provider will perform a test to make sure that BRAFTOVI is right for you.
It is not known if BRAFTOVI is safe and effective in children.

Before taking BRAFTOVI, tell your healthcare provider about all of your medical conditions, including if you:

•

have had bleeding problems

•

have eye problems

•

have heart problems, including a condition called long QT syndrome

•

have been told that you have low blood levels of potassium, calcium, or magnesium

•

have liver or kidney problems

•

are pregnant or plan to become pregnant. BRAFTOVI can harm your unborn baby.

o

Females who are able to become pregnant should use effective non-hormonal birth control (contraception) during treatment with BRAFTOVI and for 2 weeks after the last dose of BRAFTOVI. Birth control methods that contain hormones (such as birth control pills, injections or transdermal systems) may not work as well during treatment with BRAFTOVI.

o

Talk to your healthcare provider about birth control methods that may be right for you during this time.

o

Your healthcare provider will do a pregnancy test before you start taking BRAFTOVI. Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with BRAFTOVI.

•

are breastfeeding or plan to breastfeed. It is not known if BRAFTOVI passes into your breast milk. Do not breastfeed during treatment with BRAFTOVI and for 2 weeks after the last dose of BRAFTOVI. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
BRAFTOVI and certain other medicines can affect each other, causing side effects or affecting how BRAFTOVI or the other medicines work.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.